18.50
-0.50
(-2.63%)
As of 11:51:47 AM GMT+1. Market Open.
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Expense
4,574
4,574
4,048
2,577
1,704
Operating Income
-4,574
-4,574
-4,048
-2,577
-1,704
Net Non Operating Interest Income Expense
32
32
41
1
--
Pretax Income
-4,602
-4,602
-4,025
-2,579
-1,718
Tax Provision
-1,182
-1,182
-833
-407
-218
Net Income Common Stockholders
-3,420
-3,420
-3,192
-2,172
-1,500
Diluted NI Available to Com Stockholders
-3,420
-3,420
-3,192
-2,172
-1,500
Basic EPS
-0.04
--
-0.05
-0.03
-0.03
Diluted EPS
-0.04
--
-0.05
-0.03
-0.03
Basic Average Shares
80,992.57
--
68,069.42
67,679.33
65,332.05
Diluted Average Shares
80,992.57
--
68,069.42
67,679.33
65,332.05
Total Operating Income as Reported
-4,634
-4,634
-4,066
-2,580
-1,718
Rent Expense Supplemental
21
21
21
19
17
Total Expenses
4,574
4,574
4,048
2,577
1,704
Net Income from Continuing & Discontinued Operation
-3,420
-3,420
-3,192
-2,172
-1,500
Normalized Income
-3,420
-3,420
-3,192
-2,172
-1,500
Interest Income
32
32
41
1
--
Net Interest Income
32
32
41
1
--
EBIT
-4,574
-4,574
-4,048
-2,577
-1,704
EBITDA
-4,573
-4,573
-4,047
-2,575
-1,703
Reconciled Depreciation
1
1
1
2
1
Net Income from Continuing Operation Net Minority Interest
-3,420
-3,420
-3,192
-2,172
-1,500
Normalized EBITDA
-4,573
-4,573
-4,047
-2,575
-1,703
Tax Rate for Calcs
0
0
0
0
0
6/30/2021 - 10/11/2004
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SEELQ Seelos Therapeutics, Inc.
0.0005
+400.00%
SCLP.L Scancell Holdings plc
9.96
-5.10%
GLPGF Galapagos NV
22.39
0.00%
ONTl.XC
PRTCl.XC
GENF.L Genflow Biosciences plc
1.0399
-0.96%
AVCT.L Avacta Group Plc
38.49
-2.56%
ABVX.PA ABIVAX Société Anonyme
5.14
-2.47%
DBV.PA DBV Technologies S.A.
1.3060
-0.61%
LSB LakeShore Biopharma Co., Ltd
1.6500
+2.48%